EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis



Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis



Journal of the American Academy of Dermatology 78(6): 1207-1209.E1




(PDF emailed within 0-6 h: $19.90)

Accession: 065142623

Download citation: RISBibTeXText

DOI: 10.1016/j.jaad.2018.02.031



Related references

Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis. Journal of the American Academy of Dermatology 78(6): 1207-1209.E1, 2018

The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. Journal of Investigative Dermatology. Symposium Proceedings 4(3): 216-219, 2000

Risk of sun-induced skin cancers in patients with alopecia areata, alopecia totalis and alopecia universalis. Journal of the European Academy of Dermatology and Venereology, 2018

Long term intra muscular triamcinolone acetonide therapy in alopecia areata alopecia totalis and alopecia universalis. Archiv fuer Dermatologische Forschung 261(1): 73-76, 1978

Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. Journal Of The American Academy Of Dermatology. 35(2 Part 1): 201, 1996

Hypnose bij patinten met alopecia areata, areata totalis en alopecia universalis gedeeltelijke of totale kaalhoofdigheid. Directieve Therapie 22(3): 102-111, 2002

HLA class II alleles in long-standing alopecia totalis/alopecia universalis and long-standing patchy alopecia areata differentiate these two clinical groups. Journal of Investigative Dermatology 104(5 Suppl): 4s-5s, 1995

Adrenal steroid-genetic activity in subjects with alopecia totalis or subtotalis diffuse alopecia and alopecia areata. Italian General Review of Dermatology 15(1): 13-15, 1978

Biochemical and immunological studies on erythrocytes superoxide dismutase modified by nitric oxide in patients with alopecia areata: Implications in alopecia patchy persistent and alopecia universalis. Immunology Letters 160(1): 50-57, 2015

Topical halcinonide in alopecia areata and in alopecia totalis. Journal of Cutaneous Pathology 4(2): 47-50, 1977

An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis. Journal of Investigative Dermatology: -, 2018

Contact immunotherapy-resistant alopecia areata totalis/universalis reactive to topical corticosteroid. Journal of Dermatology 42(9): 937-939, 2016

Clinical characteristics and prognostic factors in early-onset alopecia totalis and alopecia universalis. Journal of Korean Medical Science 27(7): 799-802, 2012

Long-Term Prognosis of Alopecia Totalis and Alopecia Universalis: A Longitudinal Study with More than 10 Years of Follow-Up: Better than Reported. Dermatology 233(2-3): 250-256, 2017

Review of treatment for alopecia totalis and alopecia universalis. International Journal of Dermatology 56(8): 801-810, 2017